JOHNSON & JOHNSON

Official Publications Johnson & Johnson Börse Stuttgart

Equities

JNJ

US4781601046

Real-time Estimate Tradegate Other stock markets 09:41:02 2024-06-27 EDT			5-day change	1st Jan Change
137.1 ^EUR	-0.17%		+1.31%	-2.94%

12:39pm	US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug	RE
06-24	US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit	RE

Official Publications

SEC Filing 10Q-2	22-07-28	CO
Slide show half-year results	22-07-18	CO
1st-half-year results	22-07-18	CO
SEC Filing 8K	22-07-18	CO
Dividends	22-07-17	CO
SEC Filing 10Q-1	22-04-28	CO
SEC Filing 8K	22-04-27	CO
Slide show Q1	22-04-18	CO
SEC Filing 8K	22-04-18	CO
1st quarter results	22-04-18	CO
SEC Filing 8K	22-01-05	CO

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm

Protect and grow your investments with the help of our experts

Securing my Investments

fermer